Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
暂无分享,去创建一个
Reinhard Schliebs | Wolfgang Härtig | Roxana O. Carare | R. Carare | J. Kacza | R. Weller | J. Nicoll | R. Schliebs | W. Härtig | Roy O. Weller | C. Hawkes | Cheryl A. Hawkes | Johannes Kacza | James A. Nicoll
[1] S. Love,et al. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease , 2008 .
[2] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[3] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[4] David M Holtzman,et al. Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition , 2008, The Journal of Neuroscience.
[5] N. Inestrosa,et al. Laminin inhibits amyloid-β-peptide fibrillation , 1996, Neuroscience Letters.
[6] L. Kjellén,et al. Altered Processing of Fibronectin in Mice Lacking Heparin , 2001, The Journal of Biological Chemistry.
[7] L. Mucke,et al. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.
[8] P. Hutchins,et al. The microcirculation in experimental hypertension and aging. , 1996, Cardiovascular research.
[9] S. D. Preston,et al. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain , 2003, Neuropathology and applied neurobiology.
[10] M. Staufenbiel,et al. Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice , 2007, Neurobiology of Aging.
[11] E. Burns,et al. Changes with age in cerebral capillary morphology , 1981, Neurobiology of Aging.
[12] T. Krieg,et al. Laminins: a family of diverse multifunctional molecules of basement membranes. , 1996, The Journal of investigative dermatology.
[13] P. Wesseling,et al. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques , 2002, Neurobiology of Aging.
[14] N. Inestrosa,et al. Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[15] C. Patlak,et al. Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.
[16] H. Nonaka,et al. A study on the microvasculature of the cerebral cortex. Fundamental architecture and its senile change in the frontal cortex. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[17] H. Cserr,et al. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. , 1981, The American journal of physiology.
[18] H. Vanderstichele,et al. Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in Neurons , 2000 .
[19] T. Samorajski,et al. Age-related changes in rat brain capillaries , 1983, Neurobiology of Aging.
[20] B. Sommer,et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] E. Englund,et al. Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia , 2006, Acta Neuropathologica.
[22] Phillip B. Jones,et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.
[23] Y. Kiuchi,et al. Type IV collagen prevents amyloid β-protein fibril formation , 2002 .
[24] David R. Riddle,et al. Microvascular plasticity in aging , 2003, Ageing Research Reviews.
[25] D. Reboussin,et al. Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Disease a , 1997, Annals of the New York Academy of Sciences.
[26] M. Ghazizadeh,et al. Interaction between β-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer’s disease , 2009, Journal of Clinical Neuroscience.
[27] R. Deane,et al. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.
[28] R O Weller,et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.
[29] J. Couchman,et al. Still More Complexity in Mammalian Basement Membranes , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] N. Patel,et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis , 2004, Neuroscience Letters.
[31] M. Moskowitz,et al. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.
[32] L. Ailles,et al. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[33] N. Müller,et al. Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease , 2010, International journal of Alzheimer's disease.
[34] I. Pandrea,et al. Implications for Therapy , 2012 .
[35] J. Whitelock,et al. Perlecan: how does one molecule do so many things? , 2006, Cellular and Molecular Life Sciences CMLS.
[36] Xiaoping Xu,et al. Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[37] N. Inestrosa,et al. Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide , 2002, Peptides.
[38] M. Scheunemann,et al. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice , 2006, International Journal of Developmental Neuroscience.
[39] H. Tanila,et al. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice , 2007, Brain Research.
[40] Yong-An Chung,et al. Hypoperfusion and Ischemia in Cerebral Amyloid Angiopathy Documented by 99mTc-ECD Brain Perfusion SPECT , 2009, Journal of Nuclear Medicine.
[41] R N Kalaria,et al. Cerebral vessels in ageing and Alzheimer's disease. , 1996, Pharmacology & therapeutics.
[42] R. Carare,et al. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .
[43] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[44] Brian J Bacskai,et al. Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.
[45] R. Weller,et al. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. , 2004, Panminerva medica.
[46] R. Roos,et al. Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.
[47] R. Timpl,et al. Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes , 1999, The Journal of cell biology.
[48] N. Inestrosa,et al. Laminin inhibits amyloid-beta-peptide fibrillation. , 1996, Neuroscience letters.
[49] S. Love,et al. Angiotensin‐converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE‐1 to cerebral amyloid angiopathy , 2008, Neuropathology and applied neurobiology.
[50] L. Launer,et al. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.
[51] V. Perry,et al. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. , 2006, Journal of theoretical biology.
[52] Robia G. Pautler,et al. Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.
[53] W. Halfter,et al. Agrin Binds to β-Amyloid (Aβ), Accelerates Aβ Fibril Formation, and Is Localized to Aβ Deposits in Alzheimer's Disease Brain , 2000, Molecular and Cellular Neuroscience.
[54] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[55] R. Timpl. Macromolecular organization of basement membranes. , 1996, Current opinion in cell biology.
[56] D. Wilcock,et al. Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage , 2004, Journal of Neuroinflammation.
[57] E. Fifková,et al. Effect of age on blood vessels and neurovascular appositions in the rat dentate fascia , 1990, Neurobiology of Aging.
[58] Reinhard Schliebs,et al. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain , 2009, International Journal of Developmental Neuroscience.
[59] Karl J. Friston,et al. Decreases in Regional Cerebral Blood Flow with Normal Aging , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[60] H. Weiner,et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells , 2006, Nature Medicine.
[61] M. Staufenbiel,et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy. , 2002, Science.
[62] T. Wight,et al. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. , 1997, Journal of neurochemistry.
[63] Y. Kiuchi,et al. Disassembly of amyloid beta-protein fibril by basement membrane components. , 2002, Life Science.
[64] S. Younkin,et al. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[65] D. Mann,et al. Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen , 2006 .
[66] T. Ichimura,et al. Distribution of extracellular tracers in perivascular spaces of the rat brain , 1991, Brain Research.
[67] A. Danek,et al. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels , 2004, BMC Neuroscience.
[68] T. Wight,et al. Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .
[69] K. Jellinger,et al. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage , 2007, European journal of neurology.
[70] Ping Zhou,et al. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] Y. Kiuchi,et al. Disassembly of amyloid β-protein fibril by basement membrane components , 2002 .
[72] Mikio Shoji,et al. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.
[73] I. Ferrer,et al. Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis , 2006 .
[74] Y. Kiuchi,et al. Type IV collagen prevents amyloid beta-protein fibril formation. , 2002, Life sciences.
[75] Irene Otte-Höller,et al. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.
[76] D. Abrahamson,et al. Basement membrane proteoglycans and development. , 1993, Kidney international.
[77] L. S. Perlmutter. Microvascular pathology and vascular basement membrane components in Alzheimer's disease , 1994, Molecular Neurobiology.